Cytoplasmic and serum galectin-3 in diagnosis of thyroid malignancies

被引:43
作者
Inohara, Hidenori [1 ]
Segawa, Tatsuya [2 ]
Miyauchi, Akira [3 ]
Yoshii, Tadashi [1 ]
Nakahara, Susumu [1 ]
Raz, Avraham [4 ]
Maeda, Masahiro [2 ]
Miyoshi, Eiji [5 ]
Kinoshita, Noriaki [2 ]
Yoshida, Hiroshi [3 ]
Furukawa, Masashi [1 ]
Takenaka, Yukinori [1 ]
Takamura, Yuki [3 ]
Ito, Yasuhiro [3 ]
Taniguchi, Naoyuki [6 ]
机构
[1] Osaka Univ, Dept Otolaryngol, Sch Med, Suita, Osaka 5650871, Japan
[2] Immunobiol Labs IBL Co Ltd, Gunma, Japan
[3] Kuma Hosp, Kobe, Hyogo, Japan
[4] Karmanos Canc Inst, Tumor Progress & Metastasis Program, Detroit, MI USA
[5] Osaka Univ, Sch Med, Dept Mol Biochem & Clin Invest, Osaka, Japan
[6] Seikagaku Corp, Res Inst Microbial Dis, Dept Dis Glyc, Osaka, Japan
关键词
Enzyme-linked immunosorbent assay; Galectin-3; Thyroid; Carcinoma;
D O I
10.1016/j.bbrc.2008.09.041
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
in order to address whether galectin-3 in the sera and fine needle aspirates serve as a diagnostic marker distinguishing between benign and malignant thyroid nodules, we developed an enzyme-linked immunosorbent assay. We quantified galectin-3 in fine needle aspirates from a series of I IS patients with thyroid nodules and serum galectin-3 from another series of 46 patients, which were compared with final histology after thyroidectomy. Relative galectin-3 value (ng/mg), defined as galectin-3 concentration (ng/ml) divided by total protein concentration (mg/ml) in fine needle aspirates, was significantly higher in papillary carcinoma than in the other thyroid entities. There was no significant difference in serum galectin-3 level among patients with thyroid nodules and healthy individuals. Accordingly, relative galectin-3 value allows a definitive diagnosis of papillary carcinoma independent of cellular morphology, whereas serum galectin-3 does not serve as a marker for papillary carcinoma. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:605 / 610
页数:6
相关论文
共 21 条
[1]
MONOCLONAL-ANTIBODY AGAINST PRAD1/CYCLIN D1 STAINS NUCLEI OF TUMOR-CELLS WITH TRANSLOCATION OR AMPLIFICATION AT BCL-1 LOCUS [J].
BANNO, S ;
YOSHIKAWA, K ;
NAKAMURA, S ;
YAMAMOTO, K ;
SEITO, T ;
NITTA, M ;
TAKAHASHI, T ;
UEDA, R ;
SETO, M .
JAPANESE JOURNAL OF CANCER RESEARCH, 1994, 85 (09) :918-926
[2]
BARONDES SH, 1994, J BIOL CHEM, V269, P20807
[3]
Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions [J].
Bartolazzi, A ;
Gasbarri, A ;
Papotti, M ;
Bussolati, G ;
Lucante, T ;
Khan, A ;
Inohara, H ;
Marandino, F ;
Orlandi, F ;
Nardi, F ;
Vecchione, A ;
Tecce, R ;
Larsson, O .
LANCET, 2001, 357 (9269) :1644-1650
[4]
Chen HY, 2005, ARCH IMMUNOL THER EX, V53, P497
[5]
Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma [J].
Franc, B ;
De la Salmonière, P ;
Lange, F ;
Hoang, C ;
Louvel, A ;
De Roquancourt, A ;
Vildé, F ;
Hejblum, G ;
Chevret, S ;
Chastang, C .
HUMAN PATHOLOGY, 2003, 34 (11) :1092-1100
[6]
FINE-NEEDLE ASPIRATION BIOPSY OF THE THYROID - AN APPRAISAL [J].
GHARIB, H ;
GOELLNER, JR .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (04) :282-289
[7]
HARACH HR, 1992, DIAGN CYTOPATHOL, V8, P409
[8]
HEDLINGER C, 1988, HISTOLOGICAL TYPING
[9]
Inohara H, 1999, CANCER, V85, P2475, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2475::AID-CNCR25>3.0.CO
[10]
2-1